We will design assay proposals and work with you to map out how best to ensure success. Our dedicated team from research and development, quality and regulatory affairs ensures delivery of timely expert support.

Flat-fee milestone model

Milestone fee schedule aligned with drug development. R-Biopharm programs fully integrate with clinical development.

Partnership model for drugs under development
Partnership model for drugs under development

A complementary diagnostic test can be developed for already approved drugs. The assay provides guidance and optimizes the therapeutic use. This test can help to improve the health economic value proposition.

Start typing and press Enter to search